APO Research
Talk to an analyst

APO RESEARCH · REPORT

ADC Drug

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global ADC Drug Market Analysis and Forecast 2026-2032

22 December 2025190 pages

Choose your research edition.

Industry ResearchADC Drug Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal ADC Drug Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal ADC Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal ADC Drug Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal ADC Drug Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global ADC Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for ADC Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for ADC Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for ADC Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for ADC Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of ADC Drug include RemeGen Co., Ltd., Roche, Gilead(Immunomedics), Pfizer Inc., AstraZeneca, Seagen, Rakuten Medical and ADC Therapeutics, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for ADC Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of ADC Drug, also provides the sales of main regions and countries. Of the upcoming market potential for ADC Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the ADC Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global ADC Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for ADC Drug sales, projected growth trends, production technology, application and end-user industry.

ADC Drug Segment by Company

RemeGen Co., Ltd.

Roche

Gilead(Immunomedics)

Pfizer Inc.

AstraZeneca

Seagen

Rakuten Medical

ADC Therapeutics

ADC Drug Segment by Type

First Generation ADC Drug

Third Generation ADC Drug

Second Generation ADC Drug

ADC Drug Segment by Application

Leukemia

Lymphoma

Breast Cancer

Other

ADC Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global ADC Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of ADC Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of ADC Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of ADC Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of ADC Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, ADC Drug sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global ADC Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. First Generation ADC Drug Major Manufacturers Table 3. Third Generation ADC Drug Major Manufacturers Table 4. Second Generation ADC Drug Major Manufacturers Table 5. Global ADC Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Leukemia Major Manufacturers Table 7. Lymphoma Major Manufacturers Table 8. Breast Cancer Major Manufacturers Table 9. Other Major Manufacturers Table 10. ADC Drug Industry Trends Table 11. ADC Drug Industry Drivers Table 12. ADC Drug Industry Opportunities and Challenges Table 13. ADC Drug Industry Restraints Table 14. Global ADC Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global ADC Drug Revenue by Region (2021-2026) & (US$ Million) Table 16. Global ADC Drug Revenue by Region (2027-2032) & (US$ Million) Table 17. Global ADC Drug Revenue Market Share by Region (2021-2026) Table 18. Global ADC Drug Revenue Market Share by Region (2027-2032) Table 19. Global ADC Drug Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 20. Global ADC Drug Sales by Region (2021-2026) & (k units) Table 21. Global ADC Drug Sales by Region (2027-2032) & (k units) Table 22. Global ADC Drug Sales Market Share by Region (2021-2026) Table 23. Global ADC Drug Sales Market Share by Region (2027-2032) Table 24. Global ADC Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global ADC Drug Revenue Market Share by Manufacturers (2021-2026) Table 26. Global ADC Drug Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global ADC Drug Sales Market Share by Manufacturers (2021-2026) Table 28. Global ADC Drug Sales Price (US$/unit) of Manufacturers (2021-2026) Table 29. Global ADC Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global ADC Drug Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global ADC Drug Manufacturers, Product Type & Application Table 32. Global ADC Drug Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global ADC Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global ADC Drug Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global ADC Drug Revenue by Type (2021-2026) & (US$ Million) Table 37. Global ADC Drug Revenue by Type (2027-2032) & (US$ Million) Table 38. Global ADC Drug Revenue Market Share by Type (2021-2026) Table 39. Global ADC Drug Revenue Market Share by Type (2027-2032) Table 40. Global ADC Drug Sales by Type 2021 VS 2025 VS 2032 (k units) Table 41. Global ADC Drug Sales by Type (2021-2026) & (k units) Table 42. Global ADC Drug Sales by Type (2027-2032) & (k units) Table 43. Global ADC Drug Sales Market Share by Type (2021-2026) Table 44. Global ADC Drug Sales Market Share by Type (2027-2032) Table 45. Global ADC Drug Price by Type (2021-2026) & (US$/unit) Table 46. Global ADC Drug Price by Type (2027-2032) & (US$/unit) Table 47. Global ADC Drug Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global ADC Drug Revenue by Application (2021-2026) & (US$ Million) Table 49. Global ADC Drug Revenue by Application (2027-2032) & (US$ Million) Table 50. Global ADC Drug Revenue Market Share by Application (2021-2026) Table 51. Global ADC Drug Revenue Market Share by Application (2027-2032) Table 52. Global ADC Drug Sales by Application 2021 VS 2025 VS 2032 (k units) Table 53. Global ADC Drug Sales by Application (2021-2026) & (k units) Table 54. Global ADC Drug Sales by Application (2027-2032) & (k units) Table 55. Global ADC Drug Sales Market Share by Application (2021-2026) Table 56. Global ADC Drug Sales Market Share by Application (2027-2032) Table 57. Global ADC Drug Price by Application (2021-2026) & (US$/unit) Table 58. Global ADC Drug Price by Application (2027-2032) & (US$/unit) Table 59. RemeGen Co., Ltd. Company Information Table 60. RemeGen Co., Ltd. Business Overview Table 61. RemeGen Co., Ltd. ADC Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 62. RemeGen Co., Ltd. ADC Drug Product Portfolio Table 63. RemeGen Co., Ltd. Recent Development Table 64. Roche Company Information Table 65. Roche Business Overview Table 66. Roche ADC Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 67. Roche ADC Drug Product Portfolio Table 68. Roche Recent Development Table 69. Gilead(Immunomedics) Company Information Table 70. Gilead(Immunomedics) Business Overview Table 71. Gilead(Immunomedics) ADC Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 72. Gilead(Immunomedics) ADC Drug Product Portfolio Table 73. Gilead(Immunomedics) Recent Development Table 74. Pfizer Inc. Company Information Table 75. Pfizer Inc. Business Overview Table 76. Pfizer Inc. ADC Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. Pfizer Inc. ADC Drug Product Portfolio Table 78. Pfizer Inc. Recent Development Table 79. AstraZeneca Company Information Table 80. AstraZeneca Business Overview Table 81. AstraZeneca ADC Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 82. AstraZeneca ADC Drug Product Portfolio Table 83. AstraZeneca Recent Development Table 84. Seagen Company Information Table 85. Seagen Business Overview Table 86. Seagen ADC Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 87. Seagen ADC Drug Product Portfolio Table 88. Seagen Recent Development Table 89. Rakuten Medical Company Information Table 90. Rakuten Medical Business Overview Table 91. Rakuten Medical ADC Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. Rakuten Medical ADC Drug Product Portfolio Table 93. Rakuten Medical Recent Development Table 94. ADC Therapeutics Company Information Table 95. ADC Therapeutics Business Overview Table 96. ADC Therapeutics ADC Drug Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 97. ADC Therapeutics ADC Drug Product Portfolio Table 98. ADC Therapeutics Recent Development Table 99. North America ADC Drug Revenue by Type (2021-2026) & (US$ Million) Table 100. North America ADC Drug Revenue by Type (2027-2032) & (US$ Million) Table 101. North America ADC Drug Sales by Type (2021-2026) & (k units) Table 102. North America ADC Drug Sales by Type (2027-2032) & (k units) Table 103. North America ADC Drug Sales Price by Type (2021-2026) & (US$/unit) Table 104. North America ADC Drug Sales Price by Type (2027-2032) & (US$/unit) Table 105. North America ADC Drug Revenue by Application (2021-2026) & (US$ Million) Table 106. North America ADC Drug Revenue by Application (2027-2032) & (US$ Million) Table 107. North America ADC Drug Sales by Application (2021-2026) & (k units) Table 108. North America ADC Drug Sales by Application (2027-2032) & (k units) Table 109. North America ADC Drug Sales Price by Application (2021-2026) & (US$/unit) Table 110. North America ADC Drug Sales Price by Application (2027-2032) & (US$/unit) Table 111. North America ADC Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 112. North America ADC Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 113. North America ADC Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 114. North America ADC Drug Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 115. North America ADC Drug Sales by Country (2021-2026) & (k units) Table 116. North America ADC Drug Sales by Country (2027-2032) & (k units) Table 117. North America ADC Drug Sales Price by Country (2021-2026) & (US$/unit) Table 118. North America ADC Drug Sales Price by Country (2027-2032) & (US$/unit) Table 119. United States ADC Drug Revenue (2021-2032) & (US$ Million) Table 120. Canada ADC Drug Revenue (2021-2032) & (US$ Million) Table 121. Mexico ADC Drug Revenue (2021-2032) & (US$ Million) Table 122. Europe ADC Drug Revenue by Type (2021-2026) & (US$ Million) Table 123. Europe ADC Drug Revenue by Type (2027-2032) & (US$ Million) Table 124. Europe ADC Drug Sales by Type (2021-2026) & (k units) Table 125. Europe ADC Drug Sales by Type (2027-2032) & (k units) Table 126. Europe ADC Drug Sales Price by Type (2021-2026) & (US$/unit) Table 127. Europe ADC Drug Sales Price by Type (2027-2032) & (US$/unit) Table 128. Europe ADC Drug Revenue by Application (2021-2026) & (US$ Million) Table 129. Europe ADC Drug Revenue by Application (2027-2032) & (US$ Million) Table 130. Europe ADC Drug Sales by Application (2021-2026) & (k units) Table 131. Europe ADC Drug Sales by Application (2027-2032) & (k units) Table 132. Europe ADC Drug Sales Price by Application (2021-2026) & (US$/unit) Table 133. Europe ADC Drug Sales Price by Application (2027-2032) & (US$/unit) Table 134. Europe ADC Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 135. Europe ADC Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 136. Europe ADC Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 137. Europe ADC Drug Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 138. Europe ADC Drug Sales by Country (2021-2026) & (k units) Table 139. Europe ADC Drug Sales by Country (2027-2032) & (k units) Table 140. Europe ADC Drug Sales Price by Country (2021-2026) & (US$/unit) Table 141. Europe ADC Drug Sales Price by Country (2027-2032) & (US$/unit) Table 142. Germany ADC Drug Revenue (2021-2032) & (US$ Million) Table 143. France ADC Drug Revenue (2021-2032) & (US$ Million) Table 144. U.K. ADC Drug Revenue (2021-2032) & (US$ Million) Table 145. Italy ADC Drug Revenue (2021-2032) & (US$ Million) Table 146. Russia ADC Drug Revenue (2021-2032) & (US$ Million) Table 147. Spain ADC Drug Revenue (2021-2032) & (US$ Million) Table 148. Netherlands ADC Drug Revenue (2021-2032) & (US$ Million) Table 149. Switzerland ADC Drug Revenue (2021-2032) & (US$ Million) Table 150. Sweden ADC Drug Revenue (2021-2032) & (US$ Million) Table 151. Poland ADC Drug Revenue (2021-2032) & (US$ Million) Table 152. China ADC Drug Revenue by Type (2021-2026) & (US$ Million) Table 153. China ADC Drug Revenue by Type (2027-2032) & (US$ Million) Table 154. China ADC Drug Sales by Type (2021-2026) & (k units) Table 155. China ADC Drug Sales by Type (2027-2032) & (k units) Table 156. China ADC Drug Sales Price by Type (2021-2026) & (US$/unit) Table 157. China ADC Drug Sales Price by Type (2027-2032) & (US$/unit) Table 158. China ADC Drug Revenue by Application (2021-2026) & (US$ Million) Table 159. China ADC Drug Revenue by Application (2027-2032) & (US$ Million) Table 160. China ADC Drug Sales by Application (2021-2026) & (k units) Table 161. China ADC Drug Sales by Application (2027-2032) & (k units) Table 162. China ADC Drug Sales Price by Application (2021-2026) & (US$/unit) Table 163. China ADC Drug Sales Price by Application (2027-2032) & (US$/unit) Table 164. Asia ADC Drug Revenue by Type (2021-2026) & (US$ Million) Table 165. Asia ADC Drug Revenue by Type (2027-2032) & (US$ Million) Table 166. Asia ADC Drug Sales by Type (2021-2026) & (k units) Table 167. Asia ADC Drug Sales by Type (2027-2032) & (k units) Table 168. Asia ADC Drug Sales Price by Type (2021-2026) & (US$/unit) Table 169. Asia ADC Drug Sales Price by Type (2027-2032) & (US$/unit) Table 170. Asia ADC Drug Revenue by Application (2021-2026) & (US$ Million) Table 171. Asia ADC Drug Revenue by Application (2027-2032) & (US$ Million) Table 172. Asia ADC Drug Sales by Application (2021-2026) & (k units) Table 173. Asia ADC Drug Sales by Application (2027-2032) & (k units) Table 174. Asia ADC Drug Sales Price by Application (2021-2026) & (US$/unit) Table 175. Asia ADC Drug Sales Price by Application (2027-2032) & (US$/unit) Table 176. Asia ADC Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 177. Asia ADC Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 178. Asia ADC Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 179. Asia ADC Drug Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 180. Asia ADC Drug Sales by Country (2021-2026) & (k units) Table 181. Asia ADC Drug Sales by Country (2027-2032) & (k units) Table 182. Asia ADC Drug Sales Price by Country (2021-2026) & (US$/unit) Table 183. Asia ADC Drug Sales Price by Country (2027-2032) & (US$/unit) Table 184. Japan ADC Drug Revenue (2021-2032) & (US$ Million) Table 185. South Korea ADC Drug Revenue (2021-2032) & (US$ Million) Table 186. India ADC Drug Revenue (2021-2032) & (US$ Million) Table 187. Australia ADC Drug Revenue (2021-2032) & (US$ Million) Table 188. Taiwan ADC Drug Revenue (2021-2032) & (US$ Million) Table 189. Southeast Asia ADC Drug Revenue (2021-2032) & (US$ Million) Table 190. SAMEA ADC Drug Revenue by Type (2021-2026) & (US$ Million) Table 191. SAMEA ADC Drug Revenue by Type (2027-2032) & (US$ Million) Table 192. SAMEA ADC Drug Sales by Type (2021-2026) & (k units) Table 193. SAMEA ADC Drug Sales by Type (2027-2032) & (k units) Table 194. SAMEA ADC Drug Sales Price by Type (2021-2026) & (US$/unit) Table 195. SAMEA ADC Drug Sales Price by Type (2027-2032) & (US$/unit) Table 196. SAMEA ADC Drug Revenue by Application (2021-2026) & (US$ Million) Table 197. SAMEA ADC Drug Revenue by Application (2027-2032) & (US$ Million) Table 198. SAMEA ADC Drug Sales by Application (2021-2026) & (k units) Table 199. SAMEA ADC Drug Sales by Application (2027-2032) & (k units) Table 200. SAMEA ADC Drug Sales Price by Application (2021-2026) & (US$/unit) Table 201. SAMEA ADC Drug Sales Price by Application (2027-2032) & (US$/unit) Table 202. SAMEA ADC Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 203. SAMEA ADC Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 204. SAMEA ADC Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 205. SAMEA ADC Drug Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 206. SAMEA ADC Drug Sales by Country (2021-2026) & (k units) Table 207. SAMEA ADC Drug Sales by Country (2027-2032) & (k units) Table 208. SAMEA ADC Drug Sales Price by Country (2021-2026) & (US$/unit) Table 209. SAMEA ADC Drug Sales Price by Country (2027-2032) & (US$/unit) Table 210. Brazil ADC Drug Revenue (2021-2032) & (US$ Million) Table 211. Argentina ADC Drug Revenue (2021-2032) & (US$ Million) Table 212. Chile ADC Drug Revenue (2021-2032) & (US$ Million) Table 213. Colombia ADC Drug Revenue (2021-2032) & (US$ Million) Table 214. Peru ADC Drug Revenue (2021-2032) & (US$ Million) Table 215. Saudi Arabia ADC Drug Revenue (2021-2032) & (US$ Million) Table 216. Israel ADC Drug Revenue (2021-2032) & (US$ Million) Table 217. UAE ADC Drug Revenue (2021-2032) & (US$ Million) Table 218. Turkey ADC Drug Revenue (2021-2032) & (US$ Million) Table 219. Iran ADC Drug Revenue (2021-2032) & (US$ Million) Table 220. Egypt ADC Drug Revenue (2021-2032) & (US$ Million) Table 221. Key Raw Materials Table 222. Raw Materials Key Suppliers Table 223. ADC Drug Distributors List Table 224. ADC Drug Customers List Table 225. Research Programs/Design for This Report Table 226. Authors List of This Report Table 227. Secondary Sources Table 228. Primary Sources List of Figures Figure 1. ADC Drug Image Figure 2. Global ADC Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global ADC Drug Market Size Share 2021 VS 2025 VS 2032 Figure 4. First Generation ADC Drug Image Figure 5. Third Generation ADC Drug Image Figure 6. Second Generation ADC Drug Image Figure 7. Global ADC Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global ADC Drug Market Size Share 2021 VS 2025 VS 2032 Figure 9. Leukemia Image Figure 10. Lymphoma Image Figure 11. Breast Cancer Image Figure 12. Other Image Figure 13. Global ADC Drug Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global ADC Drug Revenue (2021-2032) & (US$ Million) Figure 15. Global ADC Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global ADC Drug Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global ADC Drug Revenue Market Share by Region (2021-2032) Figure 18. Global ADC Drug Sales (2021-2032) & (k units) Figure 19. Global ADC Drug Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 20. Global ADC Drug Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico ADC Drug Sales YoY (2021-2032) & (k units) Figure 22. Europe ADC Drug Sales YoY (2021-2032) & (k units) Figure 23. China ADC Drug Sales YoY (2021-2032) & (k units) Figure 24. Asia (Excluding China) ADC Drug Sales YoY (2021-2032) & (k units) Figure 25. South America, Middle East and Africa ADC Drug Sales YoY (2021-2032) & (k units) Figure 26. Global ADC Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global ADC Drug Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global ADC Drug Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global ADC Drug Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global ADC Drug Revenue Market Share by Type (2021-2032) Figure 32. Global ADC Drug Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 33. Global ADC Drug Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global ADC Drug Sales Market Share by Type (2021-2032) Figure 35. Global ADC Drug Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global ADC Drug Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global ADC Drug Revenue Market Share by Application (2021-2032) Figure 38. Global ADC Drug Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 39. Global ADC Drug Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global ADC Drug Sales Market Share by Application (2021-2032) Figure 41. North America ADC Drug Revenue Share by Type (2021-2032) Figure 42. North America ADC Drug Sales Share by Type (2021-2032) Figure 43. North America ADC Drug Revenue Share by Application (2021-2032) Figure 44. North America ADC Drug Sales Share by Application (2021-2032) Figure 45. North America ADC Drug Revenue Share by Country (2021-2032) Figure 46. North America ADC Drug Sales Share by Country (2021-2032) Figure 47. Europe ADC Drug Revenue Share by Type (2021-2032) Figure 48. Europe ADC Drug Sales Share by Type (2021-2032) Figure 49. Europe ADC Drug Revenue Share by Application (2021-2032) Figure 50. Europe ADC Drug Sales Share by Application (2021-2032) Figure 51. Europe ADC Drug Revenue Share by Country (2021-2032) Figure 52. Europe ADC Drug Sales Share by Country (2021-2032) Figure 53. China ADC Drug Revenue Share by Type (2021-2032) Figure 54. China ADC Drug Sales Share by Type (2021-2032) Figure 55. China ADC Drug Revenue Share by Application (2021-2032) Figure 56. China ADC Drug Sales Share by Application (2021-2032) Figure 57. Asia ADC Drug Revenue Share by Type (2021-2032) Figure 58. Asia ADC Drug Sales Share by Type (2021-2032) Figure 59. Asia ADC Drug Revenue Share by Application (2021-2032) Figure 60. Asia ADC Drug Sales Share by Application (2021-2032) Figure 61. Asia ADC Drug Revenue Share by Country (2021-2032) Figure 62. Asia ADC Drug Sales Share by Country (2021-2032) Figure 63. SAMEA ADC Drug Revenue Share by Type (2021-2032) Figure 64. SAMEA ADC Drug Sales Share by Type (2021-2032) Figure 65. SAMEA ADC Drug Revenue Share by Application (2021-2032) Figure 66. SAMEA ADC Drug Sales Share by Application (2021-2032) Figure 67. SAMEA ADC Drug Revenue Share by Country (2021-2032) Figure 68. SAMEA ADC Drug Sales Share by Country (2021-2032) Figure 69. ADC Drug Value Chain Figure 70. Manufacturing Cost Structure Figure 71. ADC Drug Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • First Generation ADC Drug
  • Third Generation ADC Drug
  • Second Generation ADC Drug
Applications
  • Leukemia
  • Lymphoma
  • Breast Cancer
  • Other
Companies covered
  • RemeGen Co., Ltd.
  • Roche
  • Gilead(Immunomedics)
  • Pfizer Inc.
  • AstraZeneca
  • Seagen
  • Rakuten Medical
  • ADC Therapeutics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 ADC Drug Market by Type
  3. 1.2.1 Global ADC Drug Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 First Generation ADC Drug
  5. 1.2.3 Third Generation ADC Drug
  6. 1.2.4 Second Generation ADC Drug
  7. 1.3 ADC Drug Market by Application
  8. 1.3.1 Global ADC Drug Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Leukemia
  10. 1.3.3 Lymphoma
  11. 1.3.4 Breast Cancer
  12. 1.3.5 Other
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 ADC Drug Market Dynamics
  1. 2.1 ADC Drug Industry Trends
  2. 2.2 ADC Drug Industry Drivers
  3. 2.3 ADC Drug Industry Opportunities and Challenges
  4. 2.4 ADC Drug Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global ADC Drug Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global ADC Drug Revenue by Region
  3. 3.2.1 Global ADC Drug Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global ADC Drug Revenue by Region (2021-2026)
  5. 3.2.3 Global ADC Drug Revenue by Region (2027-2032)
  6. 3.2.4 Global ADC Drug Revenue Market Share by Region (2021-2032)
  7. 3.3 Global ADC Drug Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global ADC Drug Sales by Region
  9. 3.4.1 Global ADC Drug Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global ADC Drug Sales by Region (2021-2026)
  11. 3.4.3 Global ADC Drug Sales by Region (2027-2032)
  12. 3.4.4 Global ADC Drug Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global ADC Drug Revenue by Manufacturers
  2. 4.1.1 Global ADC Drug Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global ADC Drug Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global ADC Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global ADC Drug Sales by Manufacturers
  6. 4.2.1 Global ADC Drug Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global ADC Drug Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global ADC Drug Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global ADC Drug Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global ADC Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global ADC Drug Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global ADC Drug Manufacturers, Product Type & Application
  13. 4.7 Global ADC Drug Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global ADC Drug Market CR5 and HHI
  16. 4.8.2 2025 ADC Drug Tier 1, Tier 2, and Tier 3
5 ADC Drug Market by Type
  1. 5.1 Global ADC Drug Revenue by Type
  2. 5.1.1 Global ADC Drug Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global ADC Drug Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global ADC Drug Revenue Market Share by Type (2021-2032)
  5. 5.2 Global ADC Drug Sales by Type
  6. 5.2.1 Global ADC Drug Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global ADC Drug Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global ADC Drug Sales Market Share by Type (2021-2032)
  9. 5.3 Global ADC Drug Price by Type
6 ADC Drug Market by Application
  1. 6.1 Global ADC Drug Revenue by Application
  2. 6.1.1 Global ADC Drug Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global ADC Drug Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global ADC Drug Revenue Market Share by Application (2021-2032)
  5. 6.2 Global ADC Drug Sales by Application
  6. 6.2.1 Global ADC Drug Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global ADC Drug Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global ADC Drug Sales Market Share by Application (2021-2032)
  9. 6.3 Global ADC Drug Price by Application
7 Company Profiles
  1. 7.1 RemeGen Co., Ltd.
  2. 7.1.1 RemeGen Co., Ltd. Company Information
  3. 7.1.2 RemeGen Co., Ltd. Business Overview
  4. 7.1.3 RemeGen Co., Ltd. ADC Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 RemeGen Co., Ltd. ADC Drug Product Portfolio
  6. 7.1.5 RemeGen Co., Ltd. Recent Developments
  7. 7.2 Roche
  8. 7.2.1 Roche Company Information
  9. 7.2.2 Roche Business Overview
  10. 7.2.3 Roche ADC Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Roche ADC Drug Product Portfolio
  12. 7.2.5 Roche Recent Developments
  13. 7.3 Gilead(Immunomedics)
  14. 7.3.1 Gilead(Immunomedics) Company Information
  15. 7.3.2 Gilead(Immunomedics) Business Overview
  16. 7.3.3 Gilead(Immunomedics) ADC Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Gilead(Immunomedics) ADC Drug Product Portfolio
  18. 7.3.5 Gilead(Immunomedics) Recent Developments
  19. 7.4 Pfizer Inc.
  20. 7.4.1 Pfizer Inc. Company Information
  21. 7.4.2 Pfizer Inc. Business Overview
  22. 7.4.3 Pfizer Inc. ADC Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Pfizer Inc. ADC Drug Product Portfolio
  24. 7.4.5 Pfizer Inc. Recent Developments
  25. 7.5 AstraZeneca
  26. 7.5.1 AstraZeneca Company Information
  27. 7.5.2 AstraZeneca Business Overview
  28. 7.5.3 AstraZeneca ADC Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 AstraZeneca ADC Drug Product Portfolio
  30. 7.5.5 AstraZeneca Recent Developments
  31. 7.6 Seagen
  32. 7.6.1 Seagen Company Information
  33. 7.6.2 Seagen Business Overview
  34. 7.6.3 Seagen ADC Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Seagen ADC Drug Product Portfolio
  36. 7.6.5 Seagen Recent Developments
  37. 7.7 Rakuten Medical
  38. 7.7.1 Rakuten Medical Company Information
  39. 7.7.2 Rakuten Medical Business Overview
  40. 7.7.3 Rakuten Medical ADC Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Rakuten Medical ADC Drug Product Portfolio
  42. 7.7.5 Rakuten Medical Recent Developments
  43. 7.8 ADC Therapeutics
  44. 7.8.1 ADC Therapeutics Company Information
  45. 7.8.2 ADC Therapeutics Business Overview
  46. 7.8.3 ADC Therapeutics ADC Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 ADC Therapeutics ADC Drug Product Portfolio
  48. 7.8.5 ADC Therapeutics Recent Developments
8 North America
  1. 8.1 North America ADC Drug Market Size by Type
  2. 8.1.1 North America ADC Drug Revenue by Type (2021-2032)
  3. 8.1.2 North America ADC Drug Sales by Type (2021-2032)
  4. 8.1.3 North America ADC Drug Price by Type (2021-2032)
  5. 8.2 North America ADC Drug Market Size by Application
  6. 8.2.1 North America ADC Drug Revenue by Application (2021-2032)
  7. 8.2.2 North America ADC Drug Sales by Application (2021-2032)
  8. 8.2.3 North America ADC Drug Price by Application (2021-2032)
  9. 8.3 North America ADC Drug Market Size by Country
  10. 8.3.1 North America ADC Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America ADC Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America ADC Drug Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe ADC Drug Market Size by Type
  2. 9.1.1 Europe ADC Drug Revenue by Type (2021-2032)
  3. 9.1.2 Europe ADC Drug Sales by Type (2021-2032)
  4. 9.1.3 Europe ADC Drug Price by Type (2021-2032)
  5. 9.2 Europe ADC Drug Market Size by Application
  6. 9.2.1 Europe ADC Drug Revenue by Application (2021-2032)
  7. 9.2.2 Europe ADC Drug Sales by Application (2021-2032)
  8. 9.2.3 Europe ADC Drug Price by Application (2021-2032)
  9. 9.3 Europe ADC Drug Market Size by Country
  10. 9.3.1 Europe ADC Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe ADC Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe ADC Drug Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China ADC Drug Market Size by Type
  2. 10.1.1 China ADC Drug Revenue by Type (2021-2032)
  3. 10.1.2 China ADC Drug Sales by Type (2021-2032)
  4. 10.1.3 China ADC Drug Price by Type (2021-2032)
  5. 10.2 China ADC Drug Market Size by Application
  6. 10.2.1 China ADC Drug Revenue by Application (2021-2032)
  7. 10.2.2 China ADC Drug Sales by Application (2021-2032)
  8. 10.2.3 China ADC Drug Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia ADC Drug Market Size by Type
  2. 11.1.1 Asia ADC Drug Revenue by Type (2021-2032)
  3. 11.1.2 Asia ADC Drug Sales by Type (2021-2032)
  4. 11.1.3 Asia ADC Drug Price by Type (2021-2032)
  5. 11.2 Asia ADC Drug Market Size by Application
  6. 11.2.1 Asia ADC Drug Revenue by Application (2021-2032)
  7. 11.2.2 Asia ADC Drug Sales by Application (2021-2032)
  8. 11.2.3 Asia ADC Drug Price by Application (2021-2032)
  9. 11.3 Asia ADC Drug Market Size by Country
  10. 11.3.1 Asia ADC Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia ADC Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia ADC Drug Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA ADC Drug Market Size by Type
  2. 12.1.1 SAMEA ADC Drug Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA ADC Drug Sales by Type (2021-2032)
  4. 12.1.3 SAMEA ADC Drug Price by Type (2021-2032)
  5. 12.2 SAMEA ADC Drug Market Size by Application
  6. 12.2.1 SAMEA ADC Drug Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA ADC Drug Sales by Application (2021-2032)
  8. 12.2.3 SAMEA ADC Drug Price by Application (2021-2032)
  9. 12.3 SAMEA ADC Drug Market Size by Country
  10. 12.3.1 SAMEA ADC Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA ADC Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA ADC Drug Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 ADC Drug Value Chain Analysis
  2. 13.1.1 ADC Drug Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 ADC Drug Production Mode & Process
  6. 13.2 ADC Drug Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 ADC Drug Distributors
  9. 13.2.3 ADC Drug Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst